<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Regen Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Regen Med</journal-id>
<journal-id journal-id-type="publisher-id">RME</journal-id>
<journal-title-group>
<journal-title>Regenerative Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1746-0751</issn>
<issn pub-type="epub">1746-076X</issn>
<publisher>
<publisher-name>Future Medicine Ltd</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27905217</article-id>
<article-id pub-id-type="pmc">5221123</article-id>
<article-id pub-id-type="doi">10.2217/rme-2016-0107</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Perspective</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>To CRISPR and beyond: the evolution of genome editing in stem cells</article-title>
<alt-title alt-title-type="running-head">Chen &amp; Knoepfler</alt-title>
<alt-title alt-title-type="running-head">To CRISPR &amp; beyond: the evolution of genome editing in stem cells</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Kuang-Yui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Knoepfler</surname>
<given-names>Paul S</given-names>
</name>
<xref ref-type="corresp" rid="C0001">*</xref>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff3"></xref>
</contrib>
<aff id="aff1"><label>1</label>Department of Cell Biology and Human Anatomy, University of California Davis School of Medicine, Davis, CA, USA</aff>
<aff id="aff2"><label>2</label>Institute of Pediatric Regenerative Medicine, Shriners Hospital For Children Northern California, Sacramento, CA, USA</aff>
<aff id="aff3"><label>3</label>Genome Center, University of California Davis, Davis, CA, USA</aff>
</contrib-group>
<author-notes>
<corresp id="C0001">*Author for correspondence: <email xlink:href="mailto:knoepfler@ucdavis.edu">knoepfler@ucdavis.edu</email></corresp>
<fn fn-type="COI-statement">
<p>
<bold>Financial &amp; competing interests disclosure</bold>
</p>
<p>This work was support by NIH grant 1R01GM116919-01 to PS Knoepfler and by NCI training fellowship T32CA108459 to KY Chen. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.</p>
<p>No writing assistance was utilized in the production of this manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>8</issue>
<fpage>801</fpage>
<lpage>816</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© Future Medicine Ltd</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="rme-11-801.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>The goal of editing the genomes of stem cells to generate model organisms and cell lines for genetic and biological studies has been pursued for decades. There is also exciting potential for future clinical impact in humans. While recent, rapid advances in targeted nuclease technologies have led to unprecedented accessibility and ease of gene editing, biology has benefited from past directed gene modification via homologous recombination, gene traps and other transgenic methodologies. Here we review the history of genome editing in stem cells (including via zinc finger nucleases, transcription activator-like effector nucleases and CRISPR–Cas9), discuss recent developments leading to the implementation of stem cell gene therapies in clinical trials and consider the prospects for future advances in this rapidly evolving field.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords: </title>
<kwd>CRISPR-Cas9</kwd>
<kwd>gene therapy</kwd>
<kwd>genome editing</kwd>
<kwd>stem cells</kwd>
<kwd>TALEN</kwd>
<kwd>ZFN</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>